South Africa Begins Groundbreaking HIV Prevention Rollouts

South Africa, Eswatini and Zambia have begun administering a new six?month HIV prevention shot in public health programmes, marking a major milestone in the HIV response across southern Africa. Lenacapavir, a long?acting preventive drug demonstrated to dramatically lower HIV transmission risk, is being rolled out as part of a larger Unitaid?supported initiative.

Researchers describe the rollout as a key component of broader strategies to reach populations at highest risk and improve prevention coverage. Widely hailed as a major public?health achievement, the injection offers a new horizon in HIV prevention where daily medication adherence has been a longstanding challenge.